Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
Megino-Luque C, Sisó P, Mota-Martorell N, Navaridas R, de la Rosa I, Urdanibia I, Albertí-Valls M, Santacana M, Pinyol M, Bonifaci N, Macià A, Llobet-Navas D, Gatius S, Matias-Guiu X, Eritja N. Megino-Luque C, et al. Among authors: eritja n. Mol Oncol. 2022 Jun;16(11):2235-2259. doi: 10.1002/1878-0261.13193. Epub 2022 Mar 2. Mol Oncol. 2022. PMID: 35167193 Free PMC article.
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors.
Barceló C, Sisó P, de la Rosa I, Megino-Luque C, Navaridas R, Maiques O, Urdanibia I, Eritja N, Soria X, Potrony M, Calbet-Llopart N, Puig S, Matías-Guiu X, Martí RM, Macià A. Barceló C, et al. Among authors: eritja n. Br J Cancer. 2022 Oct;127(6):1142-1152. doi: 10.1038/s41416-022-01886-4. Epub 2022 Jun 20. Br J Cancer. 2022. PMID: 35725813 Free PMC article.
Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness.
Sonzini G, Granados-Aparici S, Sanegre S, Diaz-Lagares A, Diaz-Martin J, de Andrea C, Eritja N, Bao-Caamano A, Costa-Fraga N, García-Ros D, Salguero-Aranda C, Davidson B, López-López R, Melero I, Navarro S, Ramon Y Cajal S, de Alava E, Matias-Guiu X, Noguera R. Sonzini G, et al. Among authors: eritja n. Front Cell Dev Biol. 2022 Nov 18;10:1052098. doi: 10.3389/fcell.2022.1052098. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36467415 Free PMC article.
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.
Gatius S, Jove M, Megino-Luque C, Albertí-Valls M, Yeramian A, Bonifaci N, Piñol M, Santacana M, Pradas I, Llobet-Navas D, Pamplona R, Matías-Guiu X, Eritja N. Gatius S, et al. Among authors: eritja n. Cancers (Basel). 2022 Jun 8;14(12):2842. doi: 10.3390/cancers14122842. Cancers (Basel). 2022. PMID: 35740505 Free PMC article.
Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation.
Eritja N, Navaridas R, Ruiz-Mitjana A, Vidal-Sabanés M, Egea J, Encinas M, Matias-Guiu X, Dolcet X. Eritja N, et al. Cancers (Basel). 2021 Oct 5;13(19):4990. doi: 10.3390/cancers13194990. Cancers (Basel). 2021. PMID: 34638474 Free PMC article.
46 results